Annual Working Capital
N/A
December 1, 2024
Summary
- EW annual working capital is not available.
Performance
EW Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
N/A
December 1, 2024
Summary
- EW quarterly working capital is not available.
Performance
EW Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
EW Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
EW Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Edwards Lifesciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.78 B(+45.0%) |
| Jun 2024 | - | $3.30 B(+7.8%) |
| Mar 2024 | - | $3.06 B(+7.7%) |
| Dec 2023 | $2.84 B(+37.0%) | $2.84 B(+0.4%) |
| Sep 2023 | - | $2.83 B(+13.6%) |
| Jun 2023 | - | $2.49 B(+14.5%) |
| Mar 2023 | - | $2.18 B(+4.9%) |
| Dec 2022 | $2.07 B(-3.5%) | $2.07 B(-20.1%) |
| Sep 2022 | - | $2.60 B(+13.2%) |
| Jun 2022 | - | $2.29 B(+0.1%) |
| Mar 2022 | - | $2.29 B(+6.7%) |
| Dec 2021 | $2.15 B(-2.2%) | $2.15 B(-15.7%) |
| Sep 2021 | - | $2.55 B(+4.6%) |
| Jun 2021 | - | $2.44 B(+7.3%) |
| Mar 2021 | - | $2.27 B(+3.3%) |
| Dec 2020 | $2.20 B(+5.5%) | $2.20 B(+3.0%) |
| Sep 2020 | - | $2.13 B(+17.4%) |
| Jun 2020 | - | $1.82 B(+3.2%) |
| Mar 2020 | - | $1.76 B(-15.4%) |
| Dec 2019 | $2.08 B(+47.6%) | $2.08 B(+6.0%) |
| Sep 2019 | - | $1.96 B(+18.5%) |
| Jun 2019 | - | $1.66 B(-3.8%) |
| Mar 2019 | - | $1.72 B(+22.1%) |
| Dec 2018 | $1.41 B(+24.9%) | $1.41 B(-14.6%) |
| Sep 2018 | - | $1.65 B(+9.2%) |
| Jun 2018 | - | $1.51 B(+7.9%) |
| Mar 2018 | - | $1.40 B(+24.2%) |
| Dec 2017 | $1.13 B(-33.9%) | $1.13 B(-38.3%) |
| Sep 2017 | - | $1.83 B(+6.4%) |
| Jun 2017 | - | $1.72 B(+20.0%) |
| Mar 2017 | - | $1.43 B(-16.0%) |
| Dec 2016 | $1.71 B(+8.6%) | $1.71 B(+4.2%) |
| Sep 2016 | - | $1.64 B(+8.7%) |
| Jun 2016 | - | $1.51 B(+10.7%) |
| Mar 2016 | - | $1.36 B(-13.4%) |
| Dec 2015 | $1.57 B(-12.9%) | $1.57 B(-2.6%) |
| Sep 2015 | - | $1.61 B(-12.9%) |
| Jun 2015 | - | $1.85 B(+0.1%) |
| Mar 2015 | - | $1.85 B(+2.5%) |
| Dec 2014 | $1.80 B(+30.8%) | $1.80 B(-4.1%) |
| Sep 2014 | - | $1.88 B(+8.3%) |
| Jun 2014 | - | $1.74 B(+39.3%) |
| Mar 2014 | - | $1.25 B(-9.6%) |
| Dec 2013 | $1.38 B(+46.1%) | $1.38 B(+11.7%) |
| Sep 2013 | - | $1.24 B(+14.8%) |
| Jun 2013 | - | $1.08 B(+1.5%) |
| Mar 2013 | - | $1.06 B(+12.3%) |
| Dec 2012 | $944.50 M | $944.50 M(-13.3%) |
| Sep 2012 | - | $1.09 B(+9.5%) |
| Jun 2012 | - | $994.50 M(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $922.80 M(+10.7%) |
| Dec 2011 | $833.30 M(+19.9%) | $833.30 M(-5.3%) |
| Sep 2011 | - | $879.90 M(-2.6%) |
| Jun 2011 | - | $903.50 M(+28.1%) |
| Mar 2011 | - | $705.10 M(+1.5%) |
| Dec 2010 | $694.80 M(+16.1%) | $694.80 M(+13.9%) |
| Sep 2010 | - | $610.20 M(-9.1%) |
| Jun 2010 | - | $671.20 M(+6.5%) |
| Mar 2010 | - | $630.50 M(+5.3%) |
| Dec 2009 | $598.70 M(+38.1%) | $598.70 M(+3.1%) |
| Sep 2009 | - | $580.90 M(+16.1%) |
| Jun 2009 | - | $500.50 M(+11.5%) |
| Mar 2009 | - | $448.80 M(+3.6%) |
| Dec 2008 | $433.40 M(+110.1%) | $433.40 M(-2.9%) |
| Sep 2008 | - | $446.40 M(+9.3%) |
| Jun 2008 | - | $408.50 M(+104.3%) |
| Mar 2008 | - | $200.00 M(-3.1%) |
| Dec 2007 | $206.30 M(-32.4%) | $206.30 M(-4.5%) |
| Sep 2007 | - | $216.00 M(-0.7%) |
| Jun 2007 | - | $217.60 M(-40.0%) |
| Mar 2007 | - | $362.70 M(+18.8%) |
| Dec 2006 | $305.40 M(-4.6%) | $305.40 M(+2.7%) |
| Sep 2006 | - | $297.40 M(-5.8%) |
| Jun 2006 | - | $315.80 M(-4.0%) |
| Mar 2006 | - | $329.00 M(+2.8%) |
| Dec 2005 | $320.00 M(+85.9%) | $320.00 M(+41.7%) |
| Sep 2005 | - | $225.80 M(-8.5%) |
| Jun 2005 | - | $246.70 M(+10.0%) |
| Mar 2005 | - | $224.20 M(+30.3%) |
| Dec 2004 | $172.10 M(-10.8%) | $172.10 M(+10.4%) |
| Sep 2004 | - | $155.90 M(-12.1%) |
| Jun 2004 | - | $177.30 M(+4.1%) |
| Mar 2004 | - | $170.30 M(-11.8%) |
| Dec 2003 | $193.00 M(+35.1%) | $193.00 M(-1.7%) |
| Sep 2003 | - | $196.30 M(-2.9%) |
| Jun 2003 | - | $202.10 M(+25.1%) |
| Mar 2003 | - | $161.50 M(+13.0%) |
| Dec 2002 | $142.90 M(+33.1%) | $142.90 M(+16.8%) |
| Sep 2002 | - | $122.30 M(-2.6%) |
| Jun 2002 | - | $125.60 M(+5.4%) |
| Mar 2002 | - | $119.20 M(+11.0%) |
| Dec 2001 | $107.40 M(+70.5%) | $107.40 M(-8.6%) |
| Sep 2001 | - | $117.50 M(+0.3%) |
| Jun 2001 | - | $117.10 M(+51.1%) |
| Mar 2001 | - | $77.50 M(+23.0%) |
| Dec 2000 | $63.00 M(-68.5%) | $63.00 M(<-9900.0%) |
| Sep 2000 | - | -$200.00 K(-99.4%) |
| Jun 2000 | - | -$36.00 M(+157.1%) |
| Mar 2000 | - | -$14.00 M |
| Dec 1999 | $200.00 M | - |
FAQ
- What is the all time high annual working capital for Edwards Lifesciences?
- What is the all time high quarterly working capital for Edwards Lifesciences?
What is the all time high annual working capital for Edwards Lifesciences?
Edwards Lifesciences all-time high annual working capital is $2.84 B
What is the all time high quarterly working capital for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly working capital is $4.78 B